| Literature DB >> 29156630 |
Bolei Li1,2,3, Yang Ge4,5,6, Yao Wu7, Jing Chen8,9,10, Hockin H K Xu11, Minggang Yang12, Mingyun Li13,14, Biao Ren15,16, Mingye Feng17,18, Michael D Weir19, Xian Peng20,21, Lei Cheng22,23,24, Xuedong Zhou25,26,27.
Abstract
The effects of dimethylaminododecyl methacrylate (DMADDM) modified titanium implants on bacterial activity and microbial ecosystem of saliva-derived biofilm were investigated for the first time. Titanium discs were coated with DMADDM solutions at mass fractions of 0 mg/mL (control), 1, 5 and 10 mg/mL, respectively. Biomass accumulation and metabolic activity of biofilms were tested using crystal violet assay and MTT (3-(4,5-Dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. 16S rRNA gene sequencing was performed to measure the microbial community. Live/dead staining and scanning electron microscopy (SEM) were used to value the structure of biofilm. The results showed that the higher mass fraction of DMADDM the coating solution had, the significantly lower the values of metabolic activity and accumulated biofilms got, as well as fewer live cells and less extracellular matrix. Moreover, 5 mg/mL of DMADDM was the most effective concentration, as well as 10 mg/mL. In microecosystem-regulation, the DMADDM modified titanium implant decreased the relative abundance of Neisseria and Actinomyces and increased the relative abundance of Lactobacillus, a probiotic for peri-implant diseases. In conclusion, via inhibiting growth and regulating microecosystem of biofilm, this novel titanium implant coating with DMADDM was promising in preventing peri-implant disease in an 'ecological manner'.Entities:
Keywords: antimocrobial material; dental implant; dimethylaminododecyl methacrylate; peri-implant diseases; saliva-derived biofilm
Mesh:
Substances:
Year: 2017 PMID: 29156630 PMCID: PMC6150392 DOI: 10.3390/molecules22112013
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Biomass accumulation and metabolic activity of saliva-derived biofilms on titanium discs. (a) Crystal violet assay for the biomass accumulation of saliva-derived biofilms on the titanium discs. (n = 6); (b) MTT assay for the metabolic activity of the biofilms (n = 6). Significant difference occurs between the bars marked with the different letters (a, b, c) (p < 0.05).
Figure 2Confocal laser scanning microscope (CLSM) of saliva-derived biofilms. Live/dead staining of biofilms on the titanium discs of the four groups. Live cells were stained green, and dead cells were stained red.
Figure 3The microbial community of saliva-derived biofilms. (a) Principal component analysis (PCA) score plot of control group (green), 1 mg/mL DMADDM group (red) 5 mg/mL DMADDM group (blue) and 10 mg/mL DMADDM group (yellow); (b) PCA score plot of 1 mg/mL DMADDM group (green) 5 mg/mL DMADDM group (yellow) and 10 mg/mL DMADDM group (blue); (c) Alpha diversity of every group was measured with the Simpson index; (d–f) showed the relative abundance of Lactobacillus, Neisseria, and Actinomyces, respectively. Significant difference can be seen between the bars marked with different letters (a, b) (p < 0.05).
Figure 4Scanning electron microscopy (SEM) micrographs of saliva-derived biofilms on titanium discs.